| TP53: a key gene in human cancer DP Guimaraes, P Hainaut Biochimie 84 (1), 83-93, 2002 | 272 | 2002 |
| Serrated pathway in colorectal carcinogenesis L Yamane, C Scapulatempo-Neto, RM Reis, DP Guimarães World journal of gastroenterology: WJG 20 (10), 2634, 2014 | 173 | 2014 |
| Absence of association between HPV DNA, TP53 codon 72 polymorphism, and risk of oesophageal cancer in a high-risk area of China DP Guimaraes, SH Lu, P Snijders, R Wilmotte, R Herrero, G Lenoir, ... Cancer letters 162 (2), 231-235, 2001 | 83 | 2001 |
| Polymorphisms of GSTP1 and GSTT1 , but not of CYP2A6 , CYP2E1 or GSTM1 , modify … A Rossini, DCM Rapozo, SC Soares Lima, DP Guimarães, MA Ferreira, ... Carcinogenesis 28 (12), 2537-2542, 2007 | 65 | 2007 |
| KRAS and BRAF mutations and MSI status in precursor lesions of colorectal cancer detected by colonoscopy LS Yamane, C Scapulatempo-Neto, L Alvarenga, CZ Oliveira, ... Oncology reports 32 (4), 1419-1426, 2014 | 58 | 2014 |
| Microbiota Profile and Impact of Fusobacterium nucleatum in Colorectal Cancer Patients of Barretos Cancer Hospital AC De Carvalho, L de Mattos Pereira, JG Datorre, W Dos Santos, ... Frontiers in oncology 9, 813, 2019 | 51 | 2019 |
| Interferon‐inducible guanylate binding protein (GBP)‐2: A novel p53‐regulated tumor marker in esophageal squamous cell carcinomas DP Guimaraes, IM Oliveira, E de Moraes, GR Paiva, DM Souza, C Barnas, ... International journal of cancer 124 (2), 272-279, 2009 | 48 | 2009 |
| Advantage of HSP110 (T17) marker inclusion for microsatellite instability (MSI) detection in colorectal cancer patients GN Berardinelli, C Scapulatempo-Neto, R Durães, MA de Oliveira, ... Oncotarget 9 (47), 28691, 2018 | 44 | 2018 |
| Mutation profiling of cancer drivers in Brazilian colorectal cancer W Dos Santos, T Sobanski, AC De Carvalho, AF Evangelista, ... Scientific reports 9 (1), 13687, 2019 | 38 | 2019 |
| Outpatient percutaneous endoscopic gastrostomy in selected head and neck cancer patients GF de Souza e Mello, HP Lukashok, GC Meine, IA Small, ... Surgical endoscopy 23, 1487-1493, 2009 | 38 | 2009 |
| Low frequency of TERT promoter mutations in gastrointestinal stromal tumors (GISTs) NC Campanella, R Celestino, A Pestana, C Scapulatempo-Neto, ... European Journal of Human Genetics 23 (6), 877-879, 2015 | 34 | 2015 |
| The relation of HPV infection and expression of p53 and p16 proteins in esophageal squamous cells carcinoma PRA Pastrez, VS Mariano, AM da Costa, EM Silva, C Scapulatempo-Neto, ... Journal of Cancer 8 (6), 1062, 2017 | 33 | 2017 |
| The performance of colorectal cancer screening in Brazil: the first two years of the implementation program in Barretos Cancer Hospital DP Guimaraes, LA Mantuan, MA De Oliveira, RL Junior, AM Costa, ... Cancer prevention research 14 (2), 241-252, 2021 | 31 | 2021 |
| Prognostic relevance of KIT and PDGFRA mutations in gastrointestinal stromal tumors E Braggio, DDA Braggio, IA Small, LF Lopes, M Valadão, ME Gouveia, ... Anticancer research 30 (6), 2407-2414, 2010 | 30 | 2010 |
| Comparison of a new-generation fecal immunochemical test (FIT) with guaiac fecal occult blood test (gFOBT) in detecting colorectal neoplasia among colonoscopy-referral patients DP Guimarães, JH Fregnani, RM Reis, LN Taveira, C Scapulatempo-Neto, ... Anticancer research 39 (1), 261-269, 2019 | 27 | 2019 |
| TP53 mutation profile of esophageal squamous cell carcinomas of patients from Southeastern Brazil A Rossini, T de Almeida Simão, CB Marques, SC Soares-Lima, ... Mutation Research/Genetic Toxicology and Environmental Mutagenesis 696 (1 …, 2010 | 26 | 2010 |
| XAF1 mRNA expression improves progression-free and overall survival for patients with advanced bladder cancer treated with neoadjuvant chemotherapy MB Pinho, F Costas, J Sellos, R Dienstmann, PB Andrade, ... Urologic Oncology: Seminars and Original Investigations 27 (4), 382-390, 2009 | 26 | 2009 |
| The role of Fusobacterium nucleatum in colorectal carcinogenesis JG Datorre, AC de Carvalho, DP Guimaraes, RM Reis Pathobiology 88 (2), 127-140, 2021 | 24 | 2021 |
| The embryonic Brachyury transcription factor is a novel biomarker of GIST aggressiveness and poor survival F Pinto, NC Campanella, LF Abrahao-Machado, C Scapulatempo-Neto, ... Gastric Cancer 19, 651-659, 2016 | 24 | 2016 |
| HPV infection and p53 and p16 expression in esophageal cancer: are they prognostic factors? AM Da Costa, JHTG Fregnani, PRA Pastrez, VS Mariano, EM Silva, ... Infectious agents and cancer 12, 1-9, 2017 | 23 | 2017 |
